table of content
1 Passive Transdermal Drug Delivery Market Overview
1.1 Product Overview and Scope of Passive Transdermal Drug Delivery
1.2 Passive Transdermal Drug Delivery Segment by Type
1.2.1 Global Passive Transdermal Drug Delivery Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Microfluidics
1.2.3 Smart Pill Technology (SPT)
1.3 Passive Transdermal Drug Delivery Segment by Application
1.3.1 Global Passive Transdermal Drug Delivery Sales Comparison by Application: (2022-2028)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Passive Transdermal Drug Delivery Market Size Estimates and Forecasts
1.4.1 Global Passive Transdermal Drug Delivery Revenue 2017-2028
1.4.2 Global Passive Transdermal Drug Delivery Sales 2017-2028
1.4.3 Passive Transdermal Drug Delivery Market Size by Region: 2017 Versus 2021 Versus 2028
2 Passive Transdermal Drug Delivery Market Competition by Manufacturers
2.1 Global Passive Transdermal Drug Delivery Sales Market Share by Manufacturers (2017-2022)
2.2 Global Passive Transdermal Drug Delivery Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Passive Transdermal Drug Delivery Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Passive Transdermal Drug Delivery Manufacturing Sites, Area Served, Product Type
2.5 Passive Transdermal Drug Delivery Market Competitive Situation and Trends
2.5.1 Passive Transdermal Drug Delivery Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Passive Transdermal Drug Delivery Players Market Share by Revenue
2.5.3 Global Passive Transdermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Passive Transdermal Drug Delivery Retrospective Market Scenario by Region
3.1 Global Passive Transdermal Drug Delivery Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Passive Transdermal Drug Delivery Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Passive Transdermal Drug Delivery Market Facts & Figures by Country
3.3.1 North America Passive Transdermal Drug Delivery Sales by Country
3.3.2 North America Passive Transdermal Drug Delivery Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Passive Transdermal Drug Delivery Market Facts & Figures by Country
3.4.1 Europe Passive Transdermal Drug Delivery Sales by Country
3.4.2 Europe Passive Transdermal Drug Delivery Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Passive Transdermal Drug Delivery Market Facts & Figures by Region
3.5.1 Asia Pacific Passive Transdermal Drug Delivery Sales by Region
3.5.2 Asia Pacific Passive Transdermal Drug Delivery Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Passive Transdermal Drug Delivery Market Facts & Figures by Country
3.6.1 Latin America Passive Transdermal Drug Delivery Sales by Country
3.6.2 Latin America Passive Transdermal Drug Delivery Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Passive Transdermal Drug Delivery Market Facts & Figures by Country
3.7.1 Middle East and Africa Passive Transdermal Drug Delivery Sales by Country
3.7.2 Middle East and Africa Passive Transdermal Drug Delivery Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Passive Transdermal Drug Delivery Historic Market Analysis by Type
4.1 Global Passive Transdermal Drug Delivery Sales Market Share by Type (2017-2022)
4.2 Global Passive Transdermal Drug Delivery Revenue Market Share by Type (2017-2022)
4.3 Global Passive Transdermal Drug Delivery Price by Type (2017-2022)
5 Global Passive Transdermal Drug Delivery Historic Market Analysis by Application
5.1 Global Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2022)
5.2 Global Passive Transdermal Drug Delivery Revenue Market Share by Application (2017-2022)
5.3 Global Passive Transdermal Drug Delivery Price by Application (2017-2022)
6 Key Companies Profiled
6.1 3M
6.1.1 3M Corporation Information
6.1.2 3M Description and Business Overview
6.1.3 3M Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
6.1.4 3M Passive Transdermal Drug Delivery Product Portfolio
6.1.5 3M Recent Developments/Updates
6.2 Actavis, Inc.
6.2.1 Actavis, Inc. Corporation Information
6.2.2 Actavis, Inc. Description and Business Overview
6.2.3 Actavis, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Actavis, Inc. Passive Transdermal Drug Delivery Product Portfolio
6.2.5 Actavis, Inc. Recent Developments/Updates
6.3 Bayer AG
6.3.1 Bayer AG Corporation Information
6.3.2 Bayer AG Description and Business Overview
6.3.3 Bayer AG Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Bayer AG Passive Transdermal Drug Delivery Product Portfolio
6.3.5 Bayer AG Recent Developments/Updates
6.4 Boehringer Ingelheim GmbH
6.4.1 Boehringer Ingelheim GmbH Corporation Information
6.4.2 Boehringer Ingelheim GmbH Description and Business Overview
6.4.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product Portfolio
6.4.5 Boehringer Ingelheim GmbH Recent Developments/Updates
6.5 Corium International, Inc.
6.5.1 Corium International, Inc. Corporation Information
6.5.2 Corium International, Inc. Description and Business Overview
6.5.3 Corium International, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Corium International, Inc. Passive Transdermal Drug Delivery Product Portfolio
6.5.5 Corium International, Inc. Recent Developments/Updates
6.6 Echo Therapeutics, Inc.
6.6.1 Echo Therapeutics, Inc. Corporation Information
6.6.2 Echo Therapeutics, Inc. Description and Business Overview
6.6.3 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Product Portfolio
6.6.5 Echo Therapeutics, Inc. Recent Developments/Updates
6.7 GlaxoSmithKline plc
6.6.1 GlaxoSmithKline plc Corporation Information
6.6.2 GlaxoSmithKline plc Description and Business Overview
6.6.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
6.4.4 GlaxoSmithKline plc Passive Transdermal Drug Delivery Product Portfolio
6.7.5 GlaxoSmithKline plc Recent Developments/Updates
6.8 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
6.8.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporation Information
6.8.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Description and Business Overview
6.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Product Portfolio
6.8.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Developments/Updates
6.9 Mylan N.V.
6.9.1 Mylan N.V. Corporation Information
6.9.2 Mylan N.V. Description and Business Overview
6.9.3 Mylan N.V. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Mylan N.V. Passive Transdermal Drug Delivery Product Portfolio
6.9.5 Mylan N.V. Recent Developments/Updates
6.10 Novartis AG
6.10.1 Novartis AG Corporation Information
6.10.2 Novartis AG Description and Business Overview
6.10.3 Novartis AG Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Novartis AG Passive Transdermal Drug Delivery Product Portfolio
6.10.5 Novartis AG Recent Developments/Updates
6.11 Noven Pharmaceuticals, Inc.
6.11.1 Noven Pharmaceuticals, Inc. Corporation Information
6.11.2 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Description and Business Overview
6.11.3 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Product Portfolio
6.11.5 Noven Pharmaceuticals, Inc. Recent Developments/Updates
6.12 Transdermal Corp.
6.12.1 Transdermal Corp. Corporation Information
6.12.2 Transdermal Corp. Passive Transdermal Drug Delivery Description and Business Overview
6.12.3 Transdermal Corp. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Transdermal Corp. Passive Transdermal Drug Delivery Product Portfolio
6.12.5 Transdermal Corp. Recent Developments/Updates
7 Passive Transdermal Drug Delivery Manufacturing Cost Analysis
7.1 Passive Transdermal Drug Delivery Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Passive Transdermal Drug Delivery
7.4 Passive Transdermal Drug Delivery Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Passive Transdermal Drug Delivery Distributors List
8.3 Passive Transdermal Drug Delivery Customers
9 Passive Transdermal Drug Delivery Market Dynamics
9.1 Passive Transdermal Drug Delivery Industry Trends
9.2 Passive Transdermal Drug Delivery Market Drivers
9.3 Passive Transdermal Drug Delivery Market Challenges
9.4 Passive Transdermal Drug Delivery Market Restraints
10 Global Market Forecast
10.1 Passive Transdermal Drug Delivery Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Passive Transdermal Drug Delivery by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Passive Transdermal Drug Delivery by Type (2023-2028)
10.2 Passive Transdermal Drug Delivery Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Passive Transdermal Drug Delivery by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Passive Transdermal Drug Delivery by Application (2023-2028)
10.3 Passive Transdermal Drug Delivery Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Passive Transdermal Drug Delivery by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Passive Transdermal Drug Delivery by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
